Publication | Closed Access

Structure-based identification of novel sirtuin inhibitors against triple negative breast cancer: An in silico and in vitro study

Medicinal ChemistryStructure-based IdentificationBreast OncologyDrug TargetMedicineRational Drug DesignNovel Sirtuin InhibitorsVitro StudyBreast CancerAnti-cancer AgentPharmacologyRadiation OncologyDrug Discovery